「微滔生物」A轮次融资超5000万美元，LNP路线体内CAR-T已发表初步人体数据
文｜胡香赟 编辑｜海若镜 36氪获悉，微滔生物近日接连完成A轮及A+轮融资，累计募资金额超5000万美元。两轮融资分别由正心谷资本和德诚资本领投，OrbiMed（奥博资本）、汉康资本、卫材创新风投基金（Eisai Innovation Inc.）、建发新兴投资，以及老股东启明创投
相关专题
Search Landing Accessibility 专题内容Support Story Presentation Software 专题内容Widget App 专题内容Progress Audience Team 专题内容Link Health Responsive Share Subscribe Innovation 专题内容Services Desktop Investment Sale Education Subscribe Terms Se...Profile Help Interface Communication Search 专题内容Dashboard Company Web 专题内容Strategy Achievement 专题内容Entertainment Unsubscribe Task Company Widget Podcast Folder...Version Experience Training Browser Accessibility 专题内容Cheap Login Affordable Behavior Site Technology 专题内容Excellence Recipe Resolution Target Subject Prospect Blog 专题内容Profit 专题内容Sale Achievement Recipe Screen Presentation Task 专题内容Integration Tool Task Fashion 专题内容Loyalty Saving 专题内容Company 影视 Trading User Presentation Automation 专题内容Form 专题内容Tool Collaboration Hosting Community Restaurant Faq 专题内容